# Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

> **NCT03040934** · NA · UNKNOWN · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 196 (actual)

## Conditions studied

- Drug-Eluting Stents
- Percutaneous Coronary Intervention
- Tomography, Optical Coherence

## Interventions

- **DEVICE:** Firehawk sirolimus target eluting coronary stent system
- **DEVICE:** XIENCE Everolimus-Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT03040934
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-10
- **Primary completion:** 2019-09-16
- **Final completion:** 2023-10
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040934, "Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03040934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*